Chronic Fatigue Syndrome Therapeutics Market by Product and Geography - Global Forecast and Analysis 2019-2023

Global Chronic Fatigue Syndrome Therapeutics Market:

About this market

Technavio’s chronic fatigue syndrome (CGS) therapeutics market analysis considers sales from pain relievers and NSAIDs, antidepressant and antipsychotic drugs, and antimicrobial and immunomodulatory drugs. Our analysis also considers the sales of chronic fatigue syndrome therapeutics in Asia, Europe, North America, and ROW. In 2018, the pain relievers and NSAIDs segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as relieving patients from pain and reducing inflammation will play a significant role in the pain relievers and NSAIDs segment to maintain its market position. Also, our global chronic fatigue syndrome therapeutics market report looks at factors such as increasing use of off-label pharmacological treatment for CFS, increasing risk factors of CFS, and initiatives to increase awareness about CFS. However, lack of specific diagnostic tests for confirmation of CFS, lack of approved drugs for the treatment of CFS, and complex pathogenesis of CFS may hamper the growth of the chronic fatigue syndrome therapeutics industry over the forecast period.

Global Chronic Fatigue Syndrome Therapeutics Market: Overview

Increasing risk factors of CFS

Some theories indicate that viral infection, psychological stress, genetic factors increase the risk of CFS. The prevalence of CFS is four times more in women than in men. Chronic physical or emotional stress also may result in CFS. Stress affects the hypothalamic-pituitary-adrenal axis, which is a complex network that controls the body’s reaction, such as immune response, digestion, energy usage, and mood. The prevalence of stress is increasing globally due to many societal factors and work-related pressure which is increasing the risk factors of CFS. These risk factors of CFS will lead to the expansion of the global chronic fatigue syndrome therapeutics market at a CAGR of over 4% during the forecast period.

R&D of new drugs for the treatment of CFS

The lack of approved and effective drugs has led the vendors to focus on the R&D of novel drugs to cater to the unmet need in CFS pharmacological therapy. Researchers at Stanford University School of Medicine are harnessing the nanoelectronics-based diagnostic test, developed by them, to screen for drug-based treatments. These treatments are screened by adding controlled doses of several different potentially therapeutic drugs to the patient’s blood samples and performing diagnostic tests. The research funding for CFS has increased over the last couple of years. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global chronic fatigue syndrome therapeutics market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global chronic fatigue syndrome therapeutics market is moderately fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chronic fatigue syndrome therapeutics manufacturers, that include Hemispherx Biopharma Inc., Lupin Ltd., Mylan NV, Pfizer Inc., Teva Pharmaceutical Industries Ltd.

Also, the chronic fatigue syndrome therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
      • Table Product overview
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Pain relievers and NSAIDs - Market size and forecast 2018- 2023
      • Table Pain relievers and NSAIDs - Market size and forecast 2018-2023 ($ millions)
      • Table Pain relievers and NSAIDs - Year-over-year growth 2019-2023 (%)
    • Antidepressant and antipsychotic drugs - Market size and forecast 2018-2023
      • Table Antidepressant and antipsychotic drugs - Market size and forecast 2018-2023 ($ millions)
      • Table Antidepressant and antipsychotic drugs - Year-over-year growth 2019-2023 (%)
    • Antimicrobial and immunomodulatory drugs - Market size and forecast 2018-2023
      • Table Antimicrobial and immunomodulatory drugs - Market size and forecast 2018-2023 ($ millions)
      • Table Antimicrobial and immunomodulatory drugs - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
    • Development of new diagnostic tests for CFS
    • R&D of new drugs for the treatment of CFS
    • Increasing focus on investigation of role of immune system in CFS
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Hemispherx Biopharma Inc.
      • Table Hemispherx Biopharma Inc. - Vendor overview
      • Table Hemispherx Biopharma Inc. - Business segments
      • Table Hemispherx Biopharma Inc. - Organizational developments
      • Table Hemispherx Biopharma Inc. - Key offerings
    • Lupin Ltd.
      • Table Lupin Ltd. - Vendor overview
      • Table Lupin Ltd. - Business segments
      • Table Lupin Ltd. - Organizational developments
      • Table Lupin Ltd. - Geographic focus
      • Table Lupin Ltd. - Key offerings
    • Mylan NV
      • Table Mylan NV - Vendor overview
      • Table Mylan NV - Product segments
      • Table Mylan NV - Organizational developments
      • Table Mylan NV - Geographic focus
      • Table Mylan NV - Segment focus
      • Table Mylan NV - Key offerings
    • Pfizer Inc.
      • Table Pfizer Inc. - Vendor overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Organizational developments
      • Table Pfizer Inc. - Geographic focus
      • Table Pfizer Inc. - Segment focus
      • Table Pfizer Inc. - Key offerings
    • Teva Pharmaceutical Industries Ltd.
      • Table Teva Pharmaceutical Industries Ltd. - Vendor overview
      • Table Teva Pharmaceutical Industries Ltd. - Business segments
      • Table Teva Pharmaceutical Industries Ltd. - Organizational developments
      • Table Teva Pharmaceutical Industries Ltd. - Segment focus
      • Table Teva Pharmaceutical Industries Ltd. - Key offerings
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook